Previous Article | Next Article 
J Virol, March 1998, p. 2062-2071, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Efficient Gap Repair Catalyzed In Vitro by an
Intrinsic DNA Polymerase Activity of Human Immunodeficiency Virus
Type 1 Integrase
Andrea
Acel,1
Brian E.
Udashkin,1
Mark A.
Wainberg,1,2 and
Emmanuel A.
Faust1,3,*
Lady Davis Institute for Medical Research,
Sir Mortimer B. Davis-Jewish General Hospital and McGill AIDS
Center,1 and
Departments of
Medicine3 and
Microbiology,2 McGill University,
Montreal, Quebec, Canada H3T 1E2
Received 2 July 1997/Accepted 20 November 1997
 |
ABSTRACT |
Cleavage and DNA joining reactions, carried out by human
immunodeficiency virus type 1 (HIV-1) integrase, are necessary to effect the covalent insertion of HIV-1 DNA into the host genome. For
the integration of HIV-1 DNA into the cellular genome to be completed,
short gaps flanking the integrated proviral DNA must be repaired. It
has been widely assumed that host cell DNA repair enzymes are involved.
Here we report that HIV-1 integrase multimers possess an intrinsic
DNA-dependent DNA polymerase activity. The activity was characterized
by its dependence on Mg2+, resistance to
N-ethylmaleimide, and inhibition by
3'-azido-2',3'-dideoxythymidine-5'-triphosphate, coumermycin
A1, and pyridoxal 5'-phosphate. The enzyme efficiently utilized poly(dA)-oligo(dT) or self-annealing oligonucleotides as a
template primer but displayed relatively low activity with gapped calf
thymus DNA and no activity with poly(dA) or poly(rA)-oligo(dT). A
monoclonal antibody binding specifically to an epitope comprised of
amino acids 264 to 273 near the C terminus of HIV-1 integrase severely
inhibited the DNA polymerase activity. A deletion of 50 amino acids at
the C terminus of integrase drastically altered the gel filtration
properties of the DNA polymerase, although the level of activity was
unaffected by this mutation. The DNA polymerase efficiently extended a
hairpin DNA primer up to 19 nucleotides on a T20 DNA
template, although addition of the last nucleotide occurred
infrequently or not at all. The ability of integrase to repair gaps in
DNA was also investigated. We designed a series of gapped molecules
containing a single-stranded region flanked by a duplex U5 viral arm on
one side and by a duplex nonviral arm on the other side. Molecules
varied structurally depending on the size of the gap (one, two, five,
or seven nucleotides), their content of T's or C's in the
single-stranded region, whether the CA dinucleotide in the viral arm
had been replaced with a nonviral sequence, or whether they contained
5' AC dinucleotides as unpaired tails. The results indicated that the
integrase DNA polymerase is specifically designed to repair gaps
efficiently and completely, regardless of gap size, base composition,
or structural features such as the internal CA dinucleotide or unpaired
5'-terminal AC dinucleotides. When the U5 arm of the gapped DNA
substrate was removed, leaving a nongapped DNA template-primer, the
integrase DNA polymerase failed to repair the last nucleotide in the
DNA template effectively. A post-gap repair reaction did depend on the
CA dinucleotide. This secondary reaction was highly regulated. Only two
nucleotides beyond the gap were synthesized, and these were
complementary to and dependent for their synthesis on the CA
dinucleotide. We were also able to identify a specific requirement for
the C terminus of integrase in the post-gap repair reaction. The
results are consistent with a direct role for a heretofore unsuspected
DNA polymerase function of HIV-1 integrase in the repair of short gaps
flanking proviral DNA integration intermediates that arise during virus
infection.
 |
INTRODUCTION |
Integration of human
immunodeficiency virus type 1 (HIV-1) DNA is an essential step in the
replicative cycle of the virus (6, 13, 16, 29, 41). The
initial steps whereby HIV-1 DNA becomes covalently associated with the
host DNA are mediated by the viral integrase protein. Two distinct
chemical reactions are involved. In a processing step, integrase
cleaves viral DNA endonucleolytically, resulting in the removal of a GT
dinucleotide from the 3' ends of the DNA (15, 48, 51). Once
in the nucleus, concerted cleavage and DNA strand transfer reactions,
involving viral and host DNA, enable the processed 3' termini to become covalently joined to a host DNA target site. The intermediate produced
in this manner contains unpaired 5' ends adjacent to five-base gaps.
Completion of integration requires the repair of these gaps and the
joining of the 5' ends of viral DNA to the host DNA (2). The
relatively rapid kinetics of 5'-end joining in vivo has been used as a
basis on which to argue in favor of a role for integrase in this step
of integration (40). Although integrase can catalyze the
latter reaction in vitro, albeit inefficiently (28), it has
been generally assumed that host cell enzymes perform gap repair and
5'-end joining.
Structural, functional, and mutational studies have defined integrase
as a 32-kDa protein that can be divided into three distinct functional
domains (50). The catalytic core, including amino acids 50 to 212, contains a triad of acidic amino acids (Asp 64, Asp 116, and
Glu 152) that form a highly conserved D,D-35-E motif. In the
three-dimensional crystal structure, these amino acids are in close
proximity (10). Mutation of any one of these acidic residues
severely hampers the ability of integrase to catalyze endonucleolytic
cleavage and DNA strand transfer (5, 9, 12, 13, 27, 31, 32).
The C terminus binds DNA nonspecifically and is required for cleavage
and integration activity (47, 49, 52, 53). The amino
terminus contains a zinc finger or HHCC motif, which coordinates a
molar equivalent of zinc (4). This domain influences DNA
binding (21, 25, 47), although it does not bind DNA on its
own (26, 38).
In the functional integration complex, integrase is believed to act as
a multimer (11, 24, 46). Transcomplementation, in which DNA
strand transfer and cleavage activities are restored by mixing
nonfunctional mutants, implies that the active form of integrase is
minimally a dimer (46). Integrase can exist in equilibrium
between dimeric and tetrameric forms, and multimerization determinants
can be identified within the integrase protein (1). Association of one molar equivalent of zinc with a soluble mutant of
integrase favored the formation of the tetrameric form of the protein
(54).
The present study was undertaken to further characterize HIV-1
integrase by searching for novel enzymatic activities that may be
associated with this viral protein. We chose specifically to look for
an associated DNA polymerase activity in an attempt to elucidate the
final steps in integration, namely, gap repair and 5'-end joining.
 |
MATERIALS AND METHODS |
Materials.
Calf thymus DNA was from Worthington.
Poly(dA)-oligo(dT), poly(rA)-oligo(dT), poly(dA), dATP, TTP,
HindIII linker DNA 5'-pCCCAAGCTTGGG-3' in duplex form, and Sephacryl S-300 were from Pharmacia-PL
Biochemicals. Coumermycin A1, pyridoxal 5'-phosphate,
N-ethylmaleimide (NEM), and protein gel filtration standards
were from Sigma. CHAPS
{3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate} and
Escherichia coli DNA polymerase I (Klenow fragment) and the holoenzyme were from Boehringer Mannheim.
3'-Azido-2',3'-dideoxythymidine-5'-triphosphate (AZT-TP) was from
Moravek Chemicals Inc., Loma Linda, Calif. Nickel-nitrilotriacetate (NTA) Superflow resins and plasmid kits were obtained from Qiagen. Radioactive nucleotides [
-32P]dATP and
[
-32P]TTP (specific activity, 3,000 Ci/mmol) were from
New England Nuclear-Dupont, and [
-32P]ddATP and
[
-32P]dGTP were from Amersham. Guanidine hydrochloride
and urea were obtained from BioShop. Synthetic oligonucleotides were
from Sheldon Biotechnologies Inc. or from Gibco/BRL Life Technologies.
The oligonucleotides used were DISPOL 17 (5'T20ACTGCTAGAGATTTTAAAATCTCTAGCAGT3'), DISPOL 10 (5'T20TTTTTACTGCTAGAGATATCTCTAGCAGTAAAAA3'),
DISPOL 16NV (5'T20AAGCCGGGGTACCCCGGCTT3'), G1
(5'ACTGCTAGAGATTTATCTCTAGCATTTTTGTAGCTGATCCGGTATACCGGATCAGCTAC3'), G2 (5'TGCTAGAGATTTATCTCTAGCATTTTTGTAGCTGATCCGGTATAC CGGATCAGCTAC3'), G1T1
(5'ACTGCTAGAGATTTAAATCTCTAGCATGTAGCTGATCCGGTATACCGGATCAGCTAC3'), G1T7
(5'ACTGCTAGAGATTTAAATCTCTAGCATTTTTTTGTAGCTGATCCGGTATACCGGAT CAGCTAC3'),
G1T2
(5'ACTGCTAGAGATTTAAATCTCTAGCATTGTAGCTGATCCGGTATACCGGATCAGCTAC3'), G3C5
(5'ACTGCTAGAGATTTATCTCTAGCACCCCCGTAGCTGATCCGGTATACCGGATCAGCTAC 3'),
G1H
(5'ACCTCCGGAGATTTAAATCTCCGGAGTTTTTGTAGCTGATCCGGTATACCGGATCAGCTAC3'), T5H (5'TTTTTGTAGCTGATCCGGTATACCGGATCAGCTAC3'),
17-mer (5'CGGATCAGCTACAAAAA3'), 14-mer
(5'ATCAGCTACAAAAA3'), 12-mer, (5'TAGCAGTAAAAA3'),
8-mer (5'TAGCAGTA3'), 36-mer
(5'ATCAGCTACAAAAATGCTAGAGATTTATCTCTAGCA3'), and 48-mer
(5'ATCAGCTACAAAAATGCTAGAGATTTATCTCTCTAGCATTTTTGTAGCTG3'). HEPES, IPTG (isopropylthio-
-D-galactoside), and
DNA ligase were from Gibco/BRL Life Technologies. DNA-grade glass fiber
filters (GF/B) were from Whatman. Microcon filtration units were from Amicon. Ecolume scintillation fluid was from ICN. Stop solution containing formamide, bromophenol blue, and xylene cyanol FF was from
U.S. Biochemicals. Goat anti-rabbit and anti-mouse antibodies conjugated to alkaline phosphatase were obtained from Bio-Rad.
Purification of His-tagged HIV-1 integrase.
Integrase
expression from plasmid pQE30
IN or pProEX IN was induced by IPTG
in E. coli M15pREP or JM109, respectively, and purified
under denaturing conditions as described previously (18), with some modifications. pProEX IN was produced by cloning the small
HindIII fragment of pCMV IN (17) at the
HindIII site of pProEX. The amount of nickel-NTA resin
used was 1 ml of a 50% slurry for extract obtained from 200 ml of
E. coli. Renaturation from 8 M urea in 0.1 M phosphate
buffer (pH 7.5) was performed by stepwise dialysis over several days in
10 volumes of 4 and 2 M deionized urea in 50 mM HEPES-HCl (pH 7.5)-1 M
NaCl-1 mM dithiothreitol (DTT) followed by two overnight changes of
final dialysis buffer (FDB; 50 mM HEPES-HCl [pH 7.5], 1 mM DTT, 1.0 M
NaCl, 10% glycerol, 1 mM CHAPS, 0.1 mM EDTA). The renatured sample (5 ml) was concentrated to a final volume of 1 ml in a Microcon 30 filtration unit.
Sephacryl S-300 chromatography.
The integrase sample
purified by adsorption on a nickel-NTA resin was applied to a 92-ml bed
of Sephacryl S-300 in a volume of 1 ml. The column of S-300 (Bio-Rad
Econocolumn; 1 by 120 cm) was equilibrated in FDB and developed at room
temperature at a flow rate of 5 to 6 ml/h. Fractions (1 ml) were
collected with an ISCO Retriever II fraction collector and assayed for
DNA polymerase activity.
Sedimentation velocity analysis using a glycerol gradient.
Glycerol gradients were formed from 10 to 30% glycerol in FDB. Samples
of the integrase DNA polymerase were diluted 1:1 with FDB lacking
glycerol to a final volume of 180 µl prior to loading on the glycerol
gradient. Sedimentation was performed in a Beckman L8-70
ultracentrifuge at 41,000 rpm for 66 h at 4°C, using a Beckman SW41 rotor.
DNA polymerase reactions.
DNA polymerase reaction mixtures
(25 µl) contained 10 mM Tris-Cl (pH 7.5), 5 mM MgCl2, 5 mM DTT, bovine serum albumin (200 µg/ml), poly(dA)-oligo(dT) (10 µg/ml) or DISPOL 17 DNA (0.25 µg/ml), and either 1 µM TTP with 4 µCi of [
-32P]TTP or 1 µM dATP with 4 µCi of
[
-32P]dATP, respectively. Alternatively, reactions
with T5H or gapped DNA substrate G1,
G1H, G1T1,
G1T2, G1T7, or
G2 were performed with 1 µM dATP and 1 µCi of
[
-32P]dATP. Reactions with G1 were also
conducted with 1 µM ddATP and 4 µCi of
[
-32P]ddATP. Reactions with
G3C5 were conducted with 1 µM dATP and 1 µCi of [
-32P]dATP or with 1 µM dGTP and 1 µCi of
[
-32P]dGTP. Purified integrase multimers or
Ni2+-NTA-purified integrase was added in 1 ml of FDB to a
final concentration of 0.5 nM (0.5 to 1.0 U of DNA polymerase activity)
or 30 nM, respectively. Reaction mixtures were incubated at 37°C for
1 h. Reactions were terminated in 10% trichloroacetic acid
containing 25 mM sodium pyrophosphate. Radiolabeled DNA precipitates
were collected on glass fiber filters, and radioactivity was quantified in a Canberra Packard scintillation counter, using Ecolume. For gel
analysis reactions were terminated by using formamide-dye mix and
treated as described below prior to polyacrylamide gel electrophoresis
(PAGE).
Construction and expression of a C-terminal deletion mutant of
HIV-1 integrase.
The integrase plasmid pCMV-IN RRE (17)
was subjected to partial digestion with AvaII followed by
digestion with SmaI. The recessed ends were repaired by
using E. coli DNA polymerase I (Klenow fragment).
HindIII linker DNA was added, and the linearized plasmid
was recircularized with DNA ligase. After transformation of E. coli JM109, plasmid pCMV IN
713, deleted for a C-terminal portion of the integrase gene, was identified by DNA sequencing. The
C-terminal amino acid sequence of the truncated protein is predicted to
be GPKLN. The first two amino acids correspond to residues 237 and 238 of wild-type integrase, whereas the last three amino acids in this
C-terminal sequence are derived from the plasmid DNA sequence and
replace the integrase amino acids AKL. To prepare an expression clone,
the small HindIII fragment derived from pCMV IN
713
was cloned into the HindIII site of the modified Qiagen
expression vector pQE30
, using E. coli M15/pREP. Colonies were inoculated in 2-ml cultures, induced with IPTG, and
screened for expression by immunoblot analysis using a rabbit polyclonal antibody directed to the N terminus of integrase as described previously (18). Mouse monoclonal antibody (MAb)
35 (3) was used in immunoblots in conjunction with a goat
anti-mouse secondary antibody conjugated with alkaline phosphatase.
PAGE.
DNA polymerase reaction mixtures were adjusted with
40% formamide and 0.1% bromophenol blue and xylene cyanol FF. Samples were heated to 80°C for 3 min and applied to a 20% polyacrylamide denaturing sequencing gel containing 7 M urea (0.4-mm thickness). Gels
were preelectrophoresed for 0.5 h prior to loading of the DNA
samples. Electrophoresis was done at 12 W for 2 h at constant power. Following electrophoresis, gels were soaked in 15%
methanol-5% acetic acid for 15 min and then in water for 5 min. Gels
were dried under vacuum and placed against Kodak Biomax film at
80°C.
 |
RESULTS |
Copurification of DNA polymerase activity with integrase
multimers.
A His6-tagged recombinant HIV-1 integrase
fusion protein of 35 kDa was purified from bacterial extracts under
denaturing conditions using a Ni2+-NTA affinity resin as
described in Materials and Methods. Following renaturation, a DNA
polymerase activity was detected in the purified integrase preparation
(Table 1). The DNA polymerase was
purified further by gel filtration using an S-300 column. The DNA
polymerase eluted as a single peak of activity ahead of the
-amylase
marker (Mr = 200,000) coinciding with multimeric
forms of integrase (Fig. 1). The
symmetrical elution profile was suggestive of a monodisperse, homogeneous enzyme. Dimeric forms of integrase eluted ahead of the
bovine serum albumin standard, as expected. Although integrase dimers
constituted the major form of integrase in the sample, little or no DNA
polymerase activity coeluted with this form of integrase (Fig. 1).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 1.
Analysis of DNA polymerase activity by molecular
exclusion chromatography. Integrase was purified by elution from a
nickel chelate resin and applied to a Sephacryl S-300 column as
described in Materials and Methods. The top panel shows the DNA
polymerase activity profile obtained with DISPOL 17 DNA and 1 µl of
each column fraction in reaction mixtures. The elution positions of
standard proteins (ADH, alcohol dehydrogenase; BSA, bovine serum
albumin) used to calibrate the column are indicated by the arrows. The
bottom panel shows an SDS-PAGE analysis of proteins in individual
fractions eluted from the S-300 column. Prior to analysis, samples were
concentrated 10-fold by centrifugation in a Microcon 30 unit. Proteins
were detected by silver staining. The position of integrase is
indicated at the left.
|
|
When analyzed further by chromatography on
n-butyl-Sepharose and hydroxylapatite or by sedimentation
in a glycerol gradient, the DNA polymerase was recovered as a single
peak of activity, confirming the presence of a single homogeneous DNA
polymerase in our integrase preparations. We also purified the DNA
polymerase sequentially through Ni2+-NTA,
n-butyl-Sepharose, Sephacryl S-300, hydroxylapatite, and sedimentation in glycerol gradient. The overall recovery of DNA polymerase activity with this complicated purification protocol was
50%. However, the purity did not increase significantly beyond the
Sephacryl S-300 step. Purification of integrase monomers by sodium
dodecyl sulfate (SDS)-PAGE followed by renaturation resulted in a
relatively low but detectable level of activity. Removal of the His tag
had no effect on the level of DNA polymerase activity. We therefore
performed the experiments presented below with His-tagged integrase DNA
polymerase obtained by using the simplified S-300 purification
protocol.
Determination of the molecular weight of the DNA polymerase.
The DNA polymerase sedimented faster than bovine serum albumin
(Mr = 67,000) and alcohol dehydrogenase
(Mr = 150,000; 7.3S) but slower than
-amylase
(Mr = 200,000) in a glycerol gradient and had a
sedimentation coefficient (S20,w × 1013 s) of 9.1. A Stokes radius of 4.8 nm was determined
based on the gel filtration data in comparison with bovine serum
albumin, alcohol dehydrogenase, and catalase standards. The molecular
weight calculated according to Siegl and Monty (43) was
172,100.
Time course of the DNA polymerase reaction and dependence on DNA
concentration.
When the purified DNA polymerase was incubated at
37°C with poly(dA)-oligo(dT), DTT, MgCl2, and radioactive
TTP as the nucleotide precursor, radiolabeled DNA was readily recovered
as trichloroacetic acid-precipitable material. The reaction kinetics
were linear for up to 40 min. A self-annealing oligonucleotide
template-primer designed to fold into a 15-bp hairpin primer stem
attached to a homopolymeric T tail was also used to promote DNA
synthesis (Table 1). The DNA polymerase reaction with this
template-primer increased in a DNA-dependent manner. The optimal
DNA concentration was 5 nM. Oligonucleotide template-primers with a
15-bp hairpin primer stem containing either a nonviral sequence or the
HIV-1 U5 long terminal repeat sequence gave identical results,
indicating that the HIV-1 U5 sequence was not essential for activity. A
template-primer without U5 sequences but with a 10-bp primer stem
(DISPOL 16NV) exhibited relatively low activity.
Analysis of template-primer and divalent cation preference and
effect of NEM.
The DNA polymerase activity obtained with a
self-annealing oligonucleotide containing a homopolymeric [poly(dT)]
template was completely dependent on the use of dATP as the
complementary nucleotide precursor; absolutely no DNA synthesis
occurred when the noncomplementary nucleotide dCTP, dGTP, or TTP was
used in place of dATP. In terms of template-primer preference, the DNA polymerase was not active with poly(dA) but was highly active with
poly(dA)-oligo(dT) (Table 1). Therefore, like all true DNA polymerases,
the integrase DNA polymerase requires a DNA primer for activity.
Poly(rA)-oligo(dT) failed to yield any detectable activity (Table 1),
ruling out the presence of a bacterial reverse transcriptase
(30). The DNA-dependent DNA polymerase activity was reduced
20-fold when Mn2+ was used in place of Mg2+
(Table 1) and therefore was Mg2+ dependent. The optimum
Mg2+ concentration was 10 mM. E. coli DNA
polymerase I, the major bacterial DNA polymerase, was able to utilize
both divalent cations almost interchangeably at this concentration.
Also, gapped calf thymus DNA was used relatively poorly as a
template-primer by integrase (Table 1), whereas E. coli DNA
polymerase I was equally active with gapped calf thymus DNA or
oligonucleotide hook template-primers. In addition, the
integrase-associated DNA polymerase activity was completely resistant
to inhibition by the sulfhydryl reagent NEM, whereas bacterial DNA
polymerases II and III are both extremely (100%) sensitive to NEM
(19, 23, 35). DNA polymerase II is also sensitive to
aphidicolin (Ki = 50 µM) (7, 22),
whereas the integrase DNA polymerase activity was aphidicolin
resistant.
Effect of a C-terminal deletion in integrase on DNA polymerase
activity.
A truncated form of integrase lacking 50 amino acids at
the C terminus was purified from a bacterial extract as described for
wild-type recombinant integrase. The mutant integrase was produced in
the same quantity as wild-type integrase and was approximately 5 kDa
smaller than the wild-type protein when analyzed by SDS-PAGE, as
expected (Fig. 2A). As shown by
immunoblotting, the truncated form of integrase was missing an antibody
epitope located at the C terminus of the protein (Fig. 2B).
Lower-molecular-weight proteins evident in the SDS-PAGE analysis
represent N-terminal fragments of integrase as confirmed by Western
analysis.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
SDS-PAGE and Western blot analysis of wild-type and
deletion mutant 713 integrase. The panel on the left shows a
silver-stained SDS-PAGE profile of wild-type (WT) and mutant ( 713)
integrase purified on a Ni2+-NTA resin; the panel on the
right shows an immunoblot analysis of 713 and WT integrase.
Nitrocellulose filters were incubated with antibody directed at the
amino terminus of integrase (N-Term) or the carboxy terminus of
integrase (C-Term) as described in Materials and Methods. The lane
marked M contained Rainbow colored protein standards.
|
|
The truncated form of integrase displayed approximately the same level
of DNA polymerase activity as wild-type integrase,
indicating that the
C-terminal 50 amino acids of integrase are
not essential for DNA
polymerase activity. According to gel filtration
analysis, the DNA
polymerase activity in this mutant integrase
preparation eluted just
after the alcohol dehydrogenase marker
protein
(
Mr = 150,000), clearly later than the DNA
polymerase
associated with wild-type integrase (Fig.
3). This alteration
in the gel filtration
properties of the DNA polymerase caused
specifically by a deletion
mutation in the integrase protein argues
strongly against contamination
with a free bacterial DNA polymerase
and points instead to an intrinsic
association of the DNA polymerase
activity with integrase.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
Sephacryl S-300 DNA polymerase activity elution profile
of wild-type ( ) and deletion mutant 713 ( ) integrase. The
mutant elution profile was superimposed on the wild-type profile given
in Fig. 1. Fractions of 1 ml were collected, and aliquots of 1 µl
were assayed for DNA polymerase activity as described in Materials and
Methods.
|
|
AZT-TP inhibits the integrase DNA polymerase activity.
Next,
we investigated the effects of the nucleotide analog AZT-TP on the
integrase DNA polymerase. AZT-TP inhibited the integrase DNA polymerase
with a 50% inhibitory concentration (IC50) of 220 µM
(Fig. 4). This value was reduced to 15 µM in the case of polymerization of TMP, possibly because
incorporation of AZT-5'-monophosphate into growing DNA chains caused
chain termination. Azidothymidine did not affect DNA polymerase
activity up to 500 µM. We also found that E. coli DNA
polymerase I was insensitive to AZT-TP up to a concentration of 500 µM. Thus, the effect of AZT-TP on DNA polymerase activity (when
polymerizing dAMP residues into DNA) was identical to the effect on the
other known activities of integrase (36). The sensitivity of
the putative integrase DNA polymerase activity to AZT-TP (when
polymerizing TMP residues into DNA) serves to further distinguish this
activity from E. coli DNA polymerase I.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of AZT-TP on DNA polymerase activity. DNA
polymerase reactions were conducted in the presence of various
concentrations of AZT-TP, using either DISPOL 17 DNA ( ) or
poly(dA)-oligo(dT) ( ) as a template primer. The DNA polymerase
assays were done in triplicate.
|
|
The nucleotide polymerizing capability of HIV-1 integrase was also
inhibited by coumermycin A
1 (IC
50 = 50 µM)
and by pyridoxal
5'-phosphate (IC
50 = 480 µM), compounds
that inhibit other functions
of HIV-1 integrase at somewhat lower
concentrations (
36).
Neutralization of DNA polymerase activity by a MAb.
To obtain
further evidence that integrase has an intrinsic DNA polymerase
activity, we used MAb 35, directed against the sequence KAKIIRDYGK
(amino acids 264 to 273) (3), an epitope near the C terminus
of integrase. This antibody reacted with the full-length integrase
protein in immunoblots but failed to recognize a C-terminal deletion
mutant lacking 50 amino acids, as mentioned earlier (Fig. 2B). This
antibody inhibited integrase DNA polymerase by up to 85% while having
a significantly weaker effect on DNA polymerase I (Klenow fragment)
(Fig. 5) and no effect on HIV-1 reverse
transcriptase. In addition, a pool of purified MAbs directed against
HIV-1 reverse transcriptase had no effect on integrase DNA polymerase
activity under conditions that completely inactivated HIV-1 reverse
transcriptase.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 5.
Neutralization of DNA polymerase activity by an
anti-integrase MAb. Dilutions of a mouse ascites fluid containing MAb
35 were prepared in phosphate-buffered saline, and 1 µl of the
diluted antibody was added to each 25-µl reaction mixture.
Half-filled triangles represent reactions with integrase; open
triangles represent reactions with E. coli DNA polymerase I
(Klenow fragment).
|
|
Analysis of the products of the DNA polymerase reaction.
Products of DNA polymerase reactions performed on a self-annealing
template-primer with a 20-mer homopolymeric T tail (DISPOL 10) ranged
in size from +1 to +19, but +18 and +19 products predominated. However,
no +20 products were detected, implying that a template strand
consisting of one nucleotide could not be utilized by integrase (see
below). Reaction products generated under identical conditions with
E. coli DNA polymerase I (Klenow fragment) were analyzed in
parallel. The E. coli enzyme added 20 nucleotides to the
template-primer, resulting in the production of a single major DNA
product.
Gap repair by integrase DNA polymerase.
Synthetic
oligonucleotides predicted to fold into gapped DNA molecules resembling
proviral integration intermediates were used to investigate gap repair
by the putative polymerase function of HIV-1 integrase (Fig.
6). The DNA molecule G1 is
predicted to fold so as to provide a gap of five nucleotides comprised
solely of TMP template residues situated immediately adjacent to a DNA primer. The gap is flanked on one side by a 15-bp region representing host DNA and on the other side by 10 bp of DNA matching the end of the
U5 region of the HIV-1 long terminal repeat. There is a mismatched 5'
AC dinucleotide tail adjacent to the gap. Both ends of the 59-mer
molecule are hairpinned, and the duplex regions contain cleavage sites
for several restriction enzymes. The extent of DNA polymerization in
the gapped region was assessed by measuring an increase in the length
of the DNA primer strand, following cleavage of radiolabeled DNA
products with NdeII upstream of the polymerization start
site at the 3' end of the DNA molecule. When a DNA polymerase reaction
was conducted with G1 DNA as a template-primer in the
presence of [
-32P] dATP as the sole deoxynucleoside
5'-triphosphate (dNTP), polymerization of between one and five
nucleotides at the 3' end of the gapped oligonucleotide occurred (Fig.
7). Phosphorimaging analysis revealed that gaps were filled to completion (polymerization of five
nucleotides) approximately 50% of the time (Fig.
8). We also investigated the ability of
integrase to copy a five-nucleotide tail that was not part of a gapped
structure. We constructed a molecule, T5H, which was
identical to the gapped molecule referred to above but without the
viral DNA U5 arm. When the experiment outlined above was repeated with
T5H as the template-primer, five radiolabeled DNA products were once again obtained (Fig. 7). The overall level of DNA synthesis with T5H DNA was about the same as with the gapped DNA
substrate. However, polymerization of five nucleotides at the 3' end of
the T5H molecule occurred only about 3% of the time (Fig.
8). Therefore, both arms of a gapped DNA substrate are required for
efficient polymerization of the last nucleotide of a growing DNA chain
by the integrase DNA polymerase.

View larger version (10K):
[in this window]
[in a new window]
|
FIG. 6.
Schematic representation of the gapped DNA molecules
used in this study. Torsional strain in the region of the hairpin
termini probably prevents base pairing at the ends of the molecule. The
molecules feature a U5 hairpin contiguous with the CA dinucleotide to
the left of the gap (except for G1H, where five nucleotides
adjacent to the gapped region were changed to a nonviral sequence), a
5' unpaired AC tail (except for G2), and a gapped region
which varies in length and base composition adjacent to the CA
dinucleotide. The right hairpin in each molecule is composed of a
nonviral sequence which contains an NdeII cleavage site 10 nucleotides from the 3' end of the DNA.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 7.
Repair products obtained in an integrase DNA polymerase
reaction using gapped and nongapped DNAs as template primers. The
diagrams on the left and right illustrate polymerase reactions with
gapped (G1) and nongapped (T5H) DNA substrates,
respectively. Following digestion with NdeII, samples were
analyzed on a denaturing DNA sequencing gel as described in Materials
and Methods. The radiolabeled DNA fragments seen in the autoradiogram
range from 11 to 15 nucleotides in length as determined by using 5'-end
labeled oligonucleotides of known length as markers (oligonucleotides
of 8, 12, 14, and 17 nucleotides were used; see Fig. 11 for an in-gel
comparison). A1-5 refers to the number of dAMP residues
polymerized at the 3' end of the respective DNA template-primers. The
inclined planes lying over the photo of the autoradiogram represent
increases in the amount of DNA added to reaction mixtures ranging from
10 to 20 ng (lanes 1 and 2) or 10, 20, and 50 ng (lanes 3 to 5).
|
|

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 8.
Quantitative analysis of repair reactions conducted with
gapped (G1; top) and nongapped (T5H; bottom)
DNA. The radiolabeled DNA fragments seen by autoradiography were imaged
by using a detection screen. The data were scanned into a Bio-Rad
phosphorimaging unit and quantified by computer analysis of the scanned
images. The numbers 1 to 5 on the abscissa of each graph refer to the
number of dAMP residues added to the 3' end of the DNA template-primer.
The data were corrected for cumulative increases in band intensity
caused by differences in fragment size. , 5 ng; , 10 ng; , 20 ng.
|
|
Utilization of gapped DNA substrates is template dependent.
To
determine whether gap repair by the integrase DNA polymerase was
influenced by base composition, a gapped DNA molecule containing a
C5 gap (G3C5), but otherwise
identical to the G1 molecule described earlier, was
incubated with the integrase DNA polymerase in the presence of
[
-32P]dGTP as the only dNTP. In the case of dGTP
reactions, five radiolabeled DNA products, corresponding to the
addition of between one and five nucleotides at the 3' end of the DNA
substrate, were obtained after NdeII digestion (Fig.
9). Gaps were completely filled (addition of five nucleotides) 65% of the time. In contrast, no radiolabeled products were observed when reactions were conducted with
G1 DNA (contains a T5 gap) in the presence of
[
-32P]dGTP. Therefore, virtually all DNA synthesis by
the integrase DNA polymerase is template dependent and the
incorporation of G-C base pairs into the gapped region serves to
increase the relative frequency with which gaps are filled to
completion.

View larger version (43K):
[in this window]
[in a new window]
|
FIG. 9.
Influence of base composition on gap repair. Integrase
DNA polymerase reactions were conducted in the presence of dGTP with
either G1 (lane 1) or G3C5 (lane 2)
DNA. The repair products released from the G3C5
DNA substrate by NdeII digestion are indicated by
G1-5 at the lower right. The zone marked by the asterisk
marks the position of the products of incomplete digestion with
NdeII. A 36-mer marker oligonucleotide, of the structure
expected if G3 molecules participating in repair underwent
5' joining followed by cleavage at the CA dinucleotide adjacent to the
C5 gap, comigrated with the band marked 5'-joined and
processed. The structure of this repair product was not investigated
further. The arrow marks the position of repaired DNA that is not
treated with NdeII.
|
|
The results of this experiment also argue against the possibility that
radiolabeled nucleotides are used by integrase to perform
a
nucleophilic attack on the DNA substrate. To rule out this possibility,
we performed an additional experiment in which
[

-
32P]ddATP was used as the radiolabeled nucleotide.
According to
the DNA polymerase model, one nucleotide should be added
to the
G
1 DNA substrate in this case, whereas in the
nucleophilic attack
model, radiolabeling of G
1 DNA should
not occur. The results clearly
demonstrate that radiolabeled DNA
products were obtained when
ddATP was the only nucleotide present in
the reaction mixtures.
Only a single nucleotide was added to the 3' end
of G
1 DNA under
these conditions (Fig.
10) compared with reactions containing
dATP,
which resulted in efficient gap repair (addition of five
nucleotides).
This result also demonstrates clearly that the integrase
DNA polymerase
utilizes dideoxynucleotides as chain terminators.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 10.
Utilization of ddATP by the integrase DNA polymerase.
The DNA repair products obtained with a G1 gapped DNA
substrate were compared for reactions conducted either with dATP (lane
1) or ddATP (lane 2) as the nucleotide precursor. The repair products
released from the G1 DNA substrate by NdeII
digestion are indicated by A1-5 and ddA1 for
the dATP and ddATP reactions, respectively. The radiolabeled DNA repair
products ranged in size from 11 to 15 nucleotides.
|
|
Extension of DNA chains beyond a gapped region is highly
regulated.
When all four dNTPs were added to reaction mixtures in
the presence of [
-32P]dATP, gaps in G1
molecules were filled to completion about 65% of the time (Table
2). In about half of these molecules, 1 or 2 nucleotides were added beyond the 5-nucleotide gap, as
demonstrated by the production of DNA molecules 16 and 17 nucleotides
in length following digestion of the repair products with
NdeII (Fig. 11; Table 2).
The addition of these nucleotides was highly regulated. We obtained no
evidence for the synthesis of DNA chains longer than that expected for
the addition of seven nucleotides to the 3' end of the gapped DNA
substrate. The addition of two nucleotides most probably occurs by a
mechanism in which the CA dinucleotide in the U5 region is used as a
template. The two nucleotides must therefore be T and G. This
conclusion was further verified by radiolabeling the nascent DNA with
[
-32P]dGTP. In this case, only the DNA fragment
containing the G residue at the seventh position beyond the start of
the gap became radiolabeled, as expected. Similar results were obtained
in assays using gapped DNA molecules that were identical in every
respect to the G1 molecule but did not possess a 5' AC tail
(Fig. 6 and 11; Table 2). Therefore, neither gap repair nor the
addition of two nucleotides beyond the gap require a 5' tail.
Interestingly, by changing the last five nucleotides of the U5 segment,
including the CA dinucleotide, to a nonviral sequence
(G1H), the frequency of synthesis beyond the gap was
reduced from 34% to about 6% (Table 2). Furthermore, the C-terminal
truncation mutant of integrase,
713, referred to earlier, was
similarly impaired in its ability to extend DNA chains two nucleotides
beyond the gap (Table 2). Therefore, polymerization of nucleotides
beyond the gap may be regulated by the viral U5 sequence, most probably
by the CA dinucleotide that is situated immediately adjacent to the
gap, and may involve an interaction of the U5 sequence with a
C-terminal domain of integrase.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Effects of U5 sequences and a C-terminal truncation on
the distribution frequency of integrase DNA repair products
|
|

View larger version (78K):
[in this window]
[in a new window]
|
FIG. 11.
Effect of a 5' AC unpaired dinucleotide on the DNA
repair reaction. Repair reactions were conducted as described in the
text, using either tailed (G1; lane 2) or untailed
(G2; lane 3) gapped DNA as a template-primer. The lanes
marked M4 (lanes 1 and 4) contain
5'-32P-labeled oligonucleotides whose lengths (between 8 and 17 nucleotides) are indicated at the sides. The significance of the
asterisk and the arrow is explained in the legend to Fig. 9.
|
|
Similar results were obtained using G
1-type molecules with
T
1, T
2, and T
7 gaps (Fig.
6 and
12), except that in the case of
molecules with one- and two-nucleotide gaps, polymerization continued
beyond the gapped region for up to seven or eight nucleotides,
albeit
at a relatively low level. Therefore, T
1 and T
2
molecules
appeared to have partially lost the regulation inherent in
the
structure of the T
5 and T
7 gapped
molecules.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 12.
Effect of gap size on DNA repair by the integrase DNA
polymerase. The major repair products range in size from 11 to 13, 11 to 14, 11 to 17, and 11 to 19 nucleotides in the cases of
G1T1 (lane 2), G1T2
(lane 3), G1 (lane 1), and G1T7
(lane 4), respectively. Fragments of DNA corresponding to the complete
fill-in of each gap are 11, 12, 15, and 17 in the cases of
G1T1 (lane 2), G1T2
(lane 3), G1 (lane 1), and G1T7
(lane 4), respectively. The size of each DNA fragment was determined in
comparison with oligonucleotide size markers (M4 in Fig.
11). Except for lane 3, the presumed nucleotide composition of the
added nucleotides is shown opposite the repair products. In lane 3, the
four bands at the bottom represent the addition of A1,
A2, TA2, or GTA2. The sequences
(read from right to left) represent the addition of nucleotides to the
gapped DNA substrates in a 5'-3' direction. The position of a 48-mer
oligonucleotide corresponding to the structure expected for a 5'-joined
product after NdeII cleavage is shown near the top. The
significance of the asterisk and the identity of the bands near the top
of the photograph are as described above.
|
|
 |
DISCUSSION |
To the best of our knowledge, there has been no previous report of
a retroviral integrase exhibiting DNA-dependent DNA polymerase activity. In the present study, we obtained results indicating that the
integrase protein of HIV-1, a lentivirus, possesses such an intrinsic
DNA polymerase activity. Due to the novelty of this conclusion, several
criteria were applied to the catalytic activity of the putative HIV-1
integrase DNA polymerase, in an attempt to distinguish it from the
known bacterial DNA polymerases. We found that the HIV-1 integrase DNA
polymerase behaved differently from E. coli DNA polymerase I
according to no less than six independent criteria. Neither divalent
cation or template-primer preference, sensitivity to AZT-TP or an
anti-integrase MAb, or the inability to copy the last nucleotide in a
DNA template of a nongapped substrate or to extend nascent DNA chains
through a duplex region matched the behavior of E. coli DNA
polymerase I (or its counterpart, the Klenow fragment), a potential
source of contamination in our integrase preparations. E. coli DNA polymerases II and III could be ruled out as well on the
basis of their extreme sensitivity to NEM, while failure to detect
RNA-dependent DNA polymerase activity ruled out the presence of a
bacterial reverse transcriptase.
Perhaps the inhibitory effect of the well-characterized anti-integrase
antibody MAb 35 provided the strongest evidence in favor of the
intrinsic association of a DNA polymerase activity with the HIV-1
integrase protein. Also, the fact that a C-terminal truncation mutation
in integrase altered the gel filtration properties of the DNA
polymerase attests to the intrinsic association of a DNA polymerase
with the HIV-1 integrase protein.
Separation of dimeric and multimeric forms of integrase on a Sephacryl
S-300 column revealed that the DNA polymerase activity coeluted
exclusively with integrase multimers. A molecular weight determination
for the DNA polymerase of 172,100 is consistent with the suggestion
that the integrase polymerase holoenzyme is a multimer, possibly a
hexamer. The more abundant dimeric forms of integrase failed to display
any DNA polymerase activity, at least under the conditions tested so
far. It is unclear why dimers do not catalyze DNA synthesis. Since
dimeric forms of integrase possess a nucleotide binding site
(33) and bind DNA (14, 20, 34, 39, 45, 49, 52,
53), other requirements for DNA polymerization must be lacking.
It would be of interest to further purify multimeric forms of integrase
to be able to demonstrate copurification with the DNA polymerase
activity through several chromatography steps. This was difficult to do
in the present study due to the extremely low abundance of multimers
relative to other forms of integrase, mainly dimers.
Inhibition of the integrase DNA polymerase activity by AZT-TP (when
measuring polymerization of the cognate nucleotide TTP) occurred in the
10 µM range, at least 2 orders of magnitude greater than for HIV-1
reverse transcriptase. The DNA polymerase function of integrase is
therefore probably not an in vivo target for AZT-TP. Interestingly,
when the noncognate nucleotide dATP was polymerized, sensitivity of the
DNA polymerase to this inhibitor was considerably reduced and fell in
the same range observed previously for inhibition of 3' processing and
DNA strand transfer (36). The mechanism of inhibition of all
three functions of integrase by AZT-TP could therefore be similar under
these conditions. In view of these results, studies done previously
with other nucleotide analog-inhibitors of integrase (37)
should be reevaluated to determine their effects on the DNA polymerase
function of integrase compared with their effects on the 3'-processing
or DNA strand transfer reactions. As shown here for AZT-TP, other
nucleotide analogs may display a greater inhibitory effect on the DNA
polymerase function of integrase than on the other integrase-mediated
reactions.
The HIV-1 integrase DNA polymerase is capable of carrying out efficient
gap repair in vitro and has the ability to extend a DNA chain up to two
nucleotides beyond a gap. A viral U5 sequence downstream of the gap is
not required for gap repair but significantly enhances the frequency of
post-gap synthesis, indicating that recognition of a U5 viral sequence
in the DNA substrate, possibly the CA dinucleotide, may be required.
Notably, post-gap repair involves only the polymerization of viral
sequences. The 5-bp repeats that flank the integrated provirus are
derived entirely from the adjacent host cell DNA and are not lengthened
by post-gap repair. There is no net gain of viral DNA either since the
nascent DNA (one to two nucleotides) produced in the post-gap repair
reaction displaces a preexisting viral sequence; the displaced 5' tail would theoretically be removed by integrase in vivo in a subsequent DNA
strand transfer reaction. Post-gap repair may play a physiologically relevant role in HIV-1 replication by providing a mechanism for creating a new 5' tail at the virus-host DNA junction in the event that
the existing 5' tail was removed by a host cell exonuclease.
Failure to copy the last nucleotide of a DNA template that is not part
of a gapped structure is a most remarkable and defining feature of the
integrase DNA polymerase. This unusual property may be physiologically
relevant in regard to favoring the maintenance of the 3'-processed ends
of HIV-1 DNA. Yet, a one-nucleotide template is effectively copied when
it is part of a gapped DNA substrate. As far as we know, no other DNA
polymerase has been reported to behave in this way. The mechanism for
gap repair may therefore involve a requirement for the binding of
integrase to both arms of duplex DNA lying across a single-stranded
gap. In any case, integrase shows a remarkable ability to repair even
very small gaps (one nucleotide) as well as larger gaps of at least
seven nucleotides. The integrase DNA polymerase is well suited for a presumed in vivo role as a gap repair enzyme since it can copy only
homopolymers or short stretches of natural DNA where it is unlikely to
encounter a region of secondary structure.
Although they do influence post-gap repair, the C-terminal 50 amino
acids of integrase are not required for DNA polymerase activity per se
and therefore likely do not harbor active site amino acids. In view of
this result, the inhibitory effect of the C-terminal antibody MAb 35 on
DNA polymerase activity may be explained by a structural alteration at
a distal site required for polymerase activity caused by binding of the
antibody to its C-terminal epitope. Clearly, the antibody did not
affect the DNA polymerase active site directly since deletion of the
antibody binding site did not affect DNA polymerase activity.
Significantly, MAb 35 has no inhibitory effects on the 3'-processing or
DNA strand transfer activities of integrase, whose active site is
located in the core domain (3). Its effects on the DNA
polymerase are therefore not due to a general disruption of integrase
structure. It is important to note that the mechanism of inhibition of
polymerase activity was not established by the studies presented here
and may not be related to the mechanism established previously for the
effect of the Fab fragment of MAb 35 on integration activity (3). In that instance, C-terminus-specific integrase
functional multimerization was blocked by the Fab fragment, and MAb 35 was shown to be incapable of doing this. We note that the integrase we
are dealing with here is already in a multimeric, possibly hexameric,
state when the antibody is added to reaction mixtures. This is not the
case in previous work (3), where integrase is in a dimeric
form initially and is believed to multimerize upon interacting with DNA
in the presence of divalent cations.
The results of the present study do not allow us to draw a conclusion
as to whether the polymerase active site is related to the core domain
active site established previously for integration and 3' processing.
Preliminary studies have indicated that mutations in the core domain
active site amino acids do not affect polymerase activity whereas a
P109S mutation inactivates polymerase (42). The latter
mutation is known to block the 3'-processing and integration activities
of purified integrase and to abolish viral infectivity. The mutation
also exerts a profound effect on the structure of integrase since these
mutants form large aggregates in solution (9, 44). The P109S
mutation also abrogates the ability of integrase to cross-link DNA
(8). Either of these phenotypic effects of the P109 mutation
could account for its inhibitory effect on polymerase as well. Further
experiments are therefore necessary to identify the active site amino
acid(s) for the DNA polymerase activity of HIV-1 integrase, and this
remains a major goal of our research.
 |
ACKNOWLEDGMENTS |
We thank M. Parniak for providing MAbs to HIV-1 reverse
transcriptase and for many helpful suggestions throughout the course of
this work. We are grateful to Avi Shtevi for suggesting the use of
hairpinned gapped DNA substrates and for analysis of the P109S
integrase mutant. MAb 35 was generously provided by S. H. Hughes.
This work was supported by grants from the National Health and Research
Development Program of Health and Welfare Canada and the Canadian
Foundation for AIDS Research awarded to E. A. Faust.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Lady Davis
Institute for Medical Research, Sir Mortimer B. Davis-Jewish General
Hospital, 3755 Cote Saint Catherine Rd., Montreal, Quebec, Canada H3T
1E2. Phone: (514) 340-8260. Fax: (514) 340-7502. E-mail:
efaust{at}ldi.jgh.mcgill.ca.
 |
REFERENCES |
| 1.
|
Andrake, M. D., and A. M. Skalka.
1995.
Multimerization determinants reside in both the catalytic core and C terminus of avian sarcoma virus integrase.
J. Biol. Chem.
270:29299-29306[Abstract/Free Full Text].
|
| 2.
|
Andrake, M. D., and A. M. Skalka.
1996.
Retroviral integrase, putting the pieces together.
J. Biol. Chem.
271:19633-19636[Free Full Text].
|
| 3.
|
Barsov, E. V.,
W. E. Huber,
J. Marcotrigiano,
P. K. Clark,
A. D. Clark,
E. A. Arnold, and S. H. Hughes.
1996.
Inhibition of human immunodeficiency virus type 1 integrase by the Fab fragment of a specific monoclonal antibody suggests that different multimerization states are required for different enzymatic functions.
J. Virol.
70:4484-4494[Abstract].
|
| 4.
|
Burke, C. J.,
G. Sanyal,
M. W. Bruner,
J. A. Ryan,
R. L. LaFemina,
H. L. Robbins,
A. S. Zeft,
C. R. Middaugh, and M. G. Cordingley.
1992.
Structural implications of spectroscopic characterization of a putative zinc finger peptide from HIV-1 integrase.
J. Biol. Chem.
267:9639-9644[Abstract/Free Full Text].
|
| 5.
|
Bushman, F.,
A. Engelman,
I. Palmer,
P. Wingfield, and R. Craigie.
1993.
Domains of the integrase protein of human immunodeficiency virus type 1 responsible for polynucleotidyl transfer and zinc binding.
Proc. Natl. Acad. Sci. USA
90:3428-3432[Abstract/Free Full Text].
|
| 6.
|
Cannon, P. M.,
W. Wilson,
E. Byles,
S. M. Kingsman, and A. J. Kingsman.
1994.
Human immunodeficiency virus type 1 integrase: effect on viral replication of mutations at highly conserved residues.
J. Virol.
68:4768-4775[Abstract/Free Full Text].
|
| 7.
|
Chen, H.,
C. B. Lawrence,
S. K. Bryan, and R. E. Moses.
1990.
Aphidicolin inhibits DNA polymerase II of Escherichia coli, an alpha-like DNA polymerase.
Nucleic Acids Res.
18:7185-7186[Free Full Text].
|
| 8.
|
Drelich, M.,
M. Haenggi, and J. Mous.
1993.
Conserved residues Pro-109 and Asp-116 are required for interaction of the human immunodeficiency virus type 1 integrase protein with its viral DNA substrate.
J. Virol.
67:5041-5044[Abstract/Free Full Text].
|
| 9.
|
Drelich, M.,
R. Wilhelm, and J. Mous.
1992.
Identification of amino acid residues critical for endonuclease and integration activities of HIV-1 IN protein in vitro.
Virology
188:459-468[Medline].
|
| 10.
|
Dyda, F.,
A. B. Hickman,
T. M. Jenkins,
A. Engelman,
R. Craigie, and D. R. Davies.
1994.
Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases.
Science
266:1981-1986[Abstract/Free Full Text].
|
| 11.
|
Engelman, A.,
F. D. Bushman, and R. Craigie.
1993.
Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex.
EMBO J.
12:3269-3275[Medline].
|
| 12.
|
Engelman, A., and R. Craigie.
1992.
Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro.
J. Virol.
66:6361-6369[Abstract/Free Full Text].
|
| 13.
|
Engelman, A.,
G. Englund,
J. M. Orenstein,
M. A. Martin, and R. Craigie.
1995.
Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication.
J. Virol.
69:2729-2736[Abstract].
|
| 14.
|
Engelman, A.,
A. B. Hickman, and R. Craigie.
1994.
The core and carboxyl-terminal domains of the integrase protein of human immunodeficiency virus type 1 each contribute to nonspecific DNA binding.
J. Virol.
68:5911-5917[Abstract/Free Full Text].
|
| 15.
|
Engelman, A.,
K. Mizuuchi, and R. Craigie.
1991.
HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer.
Cell
61:1211-1221.
|
| 16.
|
Englund, G.,
T. S. Theodore,
E. O. Freed,
A. Engelman, and M. A. Martin.
1995.
Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1.
J. Virol.
69:3216-3219[Abstract].
|
| 17.
|
Faust, E. A.,
A. Acel,
B. Udashkin, and M. A. Wainberg.
1993.
Human immunodeficiency virus type 1 integrase stabilizes a model HIV-1 LTR plasmid in vivo.
Biochem. Mol. Biol. Int.
36:745-758.
|
| 18.
|
Faust, E. A.,
A. Garg,
L. Small,
A. Acel,
R. Wald, and B. Udashkin.
1996.
Enzymatic capability of HIS-tagged HIV-1 integrase using oligonucleotide disintegration substrates.
J. Biomed. Sci.
3:254-265.
[Medline] |
| 19.
|
Firshein, W.,
P. Strumph,
P. Benjamin,
K. Burnstein, and J. Kornacki.
1982.
Replication of a low-copy-number plasmid by a plasmid DNA-membrane complex extracted from minicells of Escherichia coli.
J. Bacteriol.
150:1234-1243[Abstract/Free Full Text].
|
| 20.
|
Haugan, I. R.,
B. M. Nilsen,
S. Worland,
L. Olsen, and D. E. Helland.
1995.
Characterization of the DNA-binding activity of HIV-1 integrase using a filter binding assay.
Biochem. Biophys. Res. Commun.
217:802-810[Medline].
|
| 21.
|
Hazuda, D. J.,
A. L. Wolfe,
J. C. Hastings,
H. L. Robbins,
P. L. Graham,
R. L. LaFemina, and E. A. Emini.
1994.
Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integrase.
J. Biol. Chem.
269:3999-4004[Abstract/Free Full Text].
|
| 22.
|
Ishino, Y.,
H. Iwasaki,
H. Fukui,
J. Mineno,
I. Kato, and H. Shinagawa.
1992.
Aphidicolin inhibits DNA polymerizing activity but not nucleolytic activity of Escherichia coli DNA polymerase II.
Biochimie
74:131-136[Medline].
|
| 23.
|
Iwasaki, H.,
A. Nakata, and G. C. Walker.
1990.
The Escherichia coli polB gene, which encodes DNA polymerase II, is regulated by the SOS system.
J. Bacteriol.
172:6268-6273[Abstract/Free Full Text].
|
| 24.
|
Jones, K. S.,
J. Coleman,
G. W. Merkel,
T. M. Laue, and A. M. Skalka.
1992.
Retroviral integrase functions as a multimer and can turn over catalytically.
J. Biol. Chem.
267:16037-16040[Abstract/Free Full Text].
|
| 25.
|
Jonsson, C. B.,
G. A. Donzella, and M. J. Roth.
1993.
Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli.
J. Biol. Chem.
268:1462-1469[Abstract/Free Full Text].
|
| 26.
|
Khan, E.,
J. P. Mack,
R. A. Katz,
J. Kulkosky, and A. M. Skalka.
1991.
Retroviral integrase domains: DNA binding and the recognition of LTR sequences.
Nucleic Acids Res.
19:851-860[Abstract/Free Full Text].
|
| 27.
|
Kulkosky, J.,
K. S. Jones,
R. Katz,
J. Mack, and A. M. Skalka.
1992.
Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases.
Mol. Cell. Biol.
12:2331-2338[Abstract/Free Full Text].
|
| 28.
|
Kulkosky, J.,
R. A. Katz,
G. Merkel, and A. M. Skalka.
1995.
Activities and substrate specificity of the evolutionarily conserved central domain of retroviral integrase.
Virology
206:448-456[Medline].
|
| 29.
|
Lafemina, R. L.,
C. L. Schneider,
H. L. Robbins,
P. L. Callahan,
K. LeGrow,
E. Roth,
W. A. Schleif, and E. A. Emini.
1992.
Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells.
J. Virol.
66:7414-7419[Abstract/Free Full Text].
|
| 30.
|
Lampson, B. C.,
M. Viswanathan,
M. Inouye, and S. Inouye.
1990.
Reverse transcriptase from Escherichia coli exists as a complex with ms DNA and is able to synthesize double-stranded DNA.
J. Biol. Chem.
265:8490-8496[Abstract/Free Full Text].
|
| 31.
|
Leavitt, A. D.,
R. B. Rose, and H. E. Varmus.
1992.
Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.
J. Virol.
66:2359-2368[Abstract/Free Full Text].
|
| 32.
|
Leavitt, A. D.,
L. Shuie, and H. E. Varmus.
1993.
Site-directed mutagenesis of HIV-1 integrase demonstrates differential effects on integrase functions in vitro.
J. Biol. Chem.
268:2113-2119[Abstract/Free Full Text].
|
| 33.
|
Lipford, J. R.,
S. T. Worland, and C. M. Farnet.
1994.
Nucleotide binding by the HIV-1 integrase protein in vitro.
J. Acquired Immune Defic. Syndr.
7:1215-1223.
|
| 34.
|
Lutzke, R. A. P.,
C. Vink, and R. H. A. Plasterk.
1994.
Characterization of the minimal DNA-binding domain of the HIV integrase protein.
Nucleic Acids Res.
22:4125-4131[Abstract/Free Full Text].
|
| 35.
|
Maki, H., and A. Kornberg.
1985.
The polymerase subunit of DNA polymerase III of Escherichia coli. II. Purification of the alpha subunit, devoid of nuclease activities.
J. Biol. Chem.
260:12987-12992[Abstract/Free Full Text].
|
| 36.
|
Mazumder, A.,
D. Cooney,
R. Agbaria,
M. Gupta, and Y. Pommier.
1994.
Inhibition of human immunodeficiency virus type 1 integrase by 3'-azido-3'-deoxythymidylate.
Proc. Natl. Acad. Sci. USA
91:5771-5775[Abstract/Free Full Text].
|
| 37.
|
Mazumder, A.,
N. Neamati,
J. P. Sommadossi,
G. Gosselin,
R. F. Schinazi,
J. L. Imbach, and Y. Pommier.
1996.
Effects of nucleotide analogues on human immunodeficiency virus type 1 integrase.
Mol. Pharmacol.
49:621-628[Abstract].
|
| 38.
|
Mumm, S. R., and D. P. Grandgenett.
1991.
Defining nucleic acid-binding properties of avian retrovirus integrase by deletion analysis.
J. Virol.
65:1160-1167[Abstract/Free Full Text].
|
| 39.
|
Pemberton, I. K.,
M. Buckle, and H. Buc.
1996.
The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II).
J. Biol. Chem.
271:1498-1506[Abstract/Free Full Text].
|
| 40.
|
Roe, T.,
S. A. Chow, and P. O. Brown.
1997.
3'-end processing and kinetics of 5'-end joining during retroviral integration in vivo.
J. Virol.
71:1334-1340[Abstract].
|
| 41.
|
Sakai, H.,
M. Kawamura,
J.-I. Sakuragi,
R. Sakuragi,
R. Shibata,
A. Ishimoto,
N. Ono,
S. Ueda, and A. Adachi.
1993.
Integration is essential for efficient gene expression of human immunodeficiency virus type 1.
J. Virol.
67:1169-1174[Abstract/Free Full Text].
|
| 42.
| Shtevi, A., R. Wald, and E. A. Faust. 1997. Unpublished observations.
|
| 43.
|
Siegl, L. M., and K. J. Monty.
1966.
Determination of molecular weights and frictional ratios of proteins in impure systems by use of gel filtration and density gradient centrifugation. Application to crude preparations of sulfite and hydroxylamine reductases.
Biochim. Biophys. Acta
112:346-362[Medline].
|
| 44.
|
Taddeo, B.,
F. Carlini,
P. Verani, and A. Engelman.
1996.
Reversion of a human immunodeficiency virus type 1 integrase mutant at a second site restores enzyme function and virus infectivity.
J. Virol.
70:8277-8284[Abstract].
|
| 45.
|
van Gent, D. C.,
Y. Elgersma,
M. W. Bolk,
C. Vink, and R. H. Plasterk.
1991.
DNA binding properties of the integrase proteins of human immunodeficiency viruses types 1 and 2.
Nucleic Acids Res.
19:3821-3827[Abstract/Free Full Text].
|
| 46.
|
van Gent, D. C.,
C. Vink,
A. M. O. Groeneger, and R. H. A. Plasterk.
1993.
Complementation between HIV integrase proteins mutated in different domains.
EMBO J.
12:3261-3267[Medline].
|
| 47.
|
Vincent, K. A.,
V. Ellison,
S. A. Chow, and P. O. Brown.
1993.
Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino terminal mutations.
J. Virol.
67:425-437[Abstract/Free Full Text].
|
| 48.
|
Vink, C.
1991.
Site-specific hydrolysis and alcoholysis of human immunodeficiency viral DNA termini mediated by the viral integrase protein.
Nucleic Acids Res.
19:6691-6698[Abstract/Free Full Text].
|
| 49.
|
Vink, C.,
A. A. M. O. Groeneger, and R. H. A. Plasterk.
1993.
Identification of the catalytic and DNA binding region of the human immunodeficiency virus type I integrase protein.
Nucleic Acids Res.
21:1419-1425[Abstract/Free Full Text].
|
| 50.
|
Vink, C., and R. H. A. Plasterk.
1993.
The human immunodeficiency virus integrase protein.
Trends Genet.
9:433-437[Medline].
|
| 51.
|
Vink, C.,
D. C. van Gent,
Y. Elgersma, and R. H. Plasterk.
1991.
Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.
J. Virol.
65:4636-4644[Abstract/Free Full Text].
|
| 52.
|
Woerner, A. M.,
M. Klutch,
J. G. Levin, and C. J. Marcus-Sekura.
1992.
Localization of DNA binding activity of HIV-1 integrase to the C-terminal half of the protein.
AIDS Res. Hum. Retroviruses
8:2433-2437.
|
| 53.
|
Woerner, A. M., and C. J. Marcus-Sekura.
1993.
Characterization of a DNA binding domain in the C-terminus of HIV-1 integrase by deletion mutagenesis.
Nucleic Acids Res.
21:3507-3511[Abstract/Free Full Text].
|
| 54.
|
Zheng, R.,
T. M. Jenkins, and R. Craigie.
1996.
Zinc folds the N-terminal domain of HIV-1 integrase, promotes multimerization and enhances catalytic activity.
Proc. Natl. Acad. Sci. USA
93:13659-13664[Abstract/Free Full Text].
|
J Virol, March 1998, p. 2062-2071, Vol. 72, No. 3
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Yant, S. R., Kay, M. A.
(2003). Nonhomologous-End-Joining Factors Regulate DNA Repair Fidelity during Sleeping Beauty Element Transposition in Mammalian Cells. Mol. Cell. Biol.
23: 8505-8518
[Abstract]
[Full Text]
-
Yoder, K. E., Bushman, F. D.
(2000). Repair of Gaps in Retroviral DNA Integration Intermediates. J. Virol.
74: 11191-11200
[Abstract]
[Full Text]
-
Baekelandt, V., Claeys, A., Cherepanov, P., De Clercq, E., De Strooper, B., Nuttin, B., Debyser, Z.
(2000). DNA-Dependent Protein Kinase Is Not Required for Efficient Lentivirus Integration. J. Virol.
74: 11278-11285
[Abstract]
[Full Text]
-
Gerton, J. L., Herschlag, D., Brown, P. O.
(1999). Stereospecificity of Reactions Catalyzed by HIV-1 Integrase. J. Biol. Chem.
274: 33480-33487
[Abstract]
[Full Text]